PDS Biotechnology Corporation

PDSB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jul 31, 2026 8-K
EFFECT Jul 21, 2026
424B4 Jul 21, 2026 424B4
S-3 Jul 10, 2026 S-3
ARS Jun 26, 2026 ARS
DEFA14A Jun 26, 2026 DEFA14A
DEF 14A Jun 26, 2026 DEF 14A
424B5 Jun 15, 2026 424B5
PRE 14A Jun 15, 2026 PRE 14A
8-K Jun 15, 2026 8-K
8-K Jun 15, 2026 8-K
8-K Jun 2, 2026 8-K
10-Q May 14, 2026 10-Q
8-K May 13, 2026 8-K
8-K May 1, 2026 8-K
EFFECT Apr 28, 2026
10-K/A Apr 28, 2026 10-K/A
S-3/A Apr 24, 2026 S-3/A
CORRESP Apr 24, 2026
8-K Apr 24, 2026 8-K
8-K Apr 15, 2026 8-K
10-K Mar 30, 2026 10-K
8-K Mar 30, 2026 8-K
4 Mar 3, 2026 FORM 4
4 Mar 3, 2026 FORM 4
← Newer Page 2 of 32 · 795 filings Older →